Biotechnology
United
States
Therapies
Rare
Diseases
Advanced
M&A Advisory
Lazard
Full Credential Description
Amicus Therapeutics. United States. Announced Date 01/06/2007. Closed Date 01/06/2007. Deal value: $75m. Initial public offering. Industry: Amicus Therapeutics is a biotechnology company focused on developing advanced therapies for rare and orphan diseases.